Team – aiabiomed.com

Our organization actively engages with leading international scientific and medical communities to remain connected with the latest advances in regenerative medicine, cellular therapies, longevity science, and translational healthcare. Membership applications have been submitted to premier global organizations that support scientific exchange, professional education, ethical standards, and the advancement of innovative therapies.

International Society for Stem Cell Research

(ISSCR)

The International Society for Stem Cell Research (ISSCR) is the world’s leading scientific organization dedicated to advancing stem cell biology and regenerative medicine. Its global community includes researchers, clinicians, educators, ethicists, regulators, and industry professionals working to advance scientific discovery, responsible innovation, and the translation of regenerative technologies into clinical applications.

International Society for Cell & Gene Therapy

(ISCT)

The International Society for Cell & Gene Therapy (ISCT) is a global organization focused on advancing the development, translation, and implementation of cell and gene therapies. ISCT brings together scientists, clinicians, industry leaders, and regulatory experts working to establish safe, scalable, and clinically applicable cellular medicine solutions.

American Academy of Stem Cell Physicians

(AASCP)

The American Academy of Stem Cell Physicians (AASCP) is a professional organization focused on physician education, clinical training, and the responsible advancement of stem cell-based therapies. AASCP brings together physicians and healthcare professionals interested in the evolving field of regenerative medicine, supporting the exchange of clinical knowledge, treatment methodologies, and emerging scientific developments.

International Peptide Society

(IPS)

The International Peptide Society (IPS) is a global scientific organization dedicated to advancing research, education, and collaboration in the field of peptide science and peptide-based therapeutics. The Society supports scientists, clinicians, and industry professionals working to understand and develop peptide technologies across healthcare, biotechnology, and personalized medicine.

Michael Nouri

PhD | Founder, Principal Investor & Visionary Developer

Michael Nouri is a distinguished engineer, technology entrepreneur, real estate developer, investor, and philanthropist whose career spans nearly four decades of innovation, leadership, and transformative business creation across multiple industries, including advanced telecommunications, smart infrastructure, heavy manufacturing, technology systems, business software development, and luxury real estate development

about ->

Samuel L. Scripps

Senior Advisor, Strategic Partnerships & Institutional Relations

Samuel L. Scripps serves as Senior Advisor for Strategic Partnerships & Institutional Relations at NGB Institute, supporting relationships across scientific, academic, philanthropic, and healthcare networks. As a member of the Scripps family, whose legacy includes founding the institution that became Scripps Research, he brings perspective on scientific philanthropy, institutional collaboration, and biomedical impact.

Oguz Murat Otay

MBA | Executive Director of International Relations & Business Development

Oguz Murat Otay is an international business executive with over 30 years of experience in global business development, strategic partnerships, investment, and cross-border market expansion. As Executive Director of International Relations & Business Development, he leads Nouri Group’s international growth initiatives, investor relations, and strategic alliances, advancing the company’s global presence in longevity medicine and regenerative healthcare.

Justin Rundle, Esq

Chief Legal & Strategic Affairs Officer | Corporate Counsel | Transaction Architect | Strategic Growth Advisor

Justin Rundle is a distinguished business attorney, trusted strategic advisor, and accomplished transaction architect whose career has been dedicated to helping visionary entrepreneurs, investors, developers, healthcare organizations, and emerging growth companies transform ambitious ideas into scalable, investment-grade enterprises.

Iraida Ermakova

Chief Digital Technology Officer | Data Analytics Specialist | Digital Health Systems Strategist |

Iraida Ermakova is a highly accomplished technology executive, data analytics leader, and enterprise systems strategist with extensive experience building and managing large-scale technology platforms for some of the world’s most influential technology companies. Her expertise spans artificial intelligence, cloud infrastructure, cybersecurity, enterprise architecture, business intelligence, data engineering, digital transformation, and healthcare technology innovation

Our institutional research collaborations connect our organization with internationally recognized biomedical research institutions, supporting scientific validation, translational innovation, and the advancement of next-generation longevity and regenerative medicine technologies.

Scripps Research

The world's leading independent biomedical research institutions

Scripps Research is a globally recognized biomedical research institution known for pioneering discoveries in molecular medicine, immunology, neuroscience, and biotechnology. Its research ecosystem supports the translation of scientific discoveries into innovative solutions that advance the future of human health and longevity.

Images shown are for informational and illustrative purposes only. They are used to represent referenced institutions and facilities and do not imply endorsement, affiliation, or partnership unless expressly stated.

Elissa Tjahjono, PhD

PhD: Biochemistry and Cell Biology | Simbryo Technologies | Rice University

Lead Scientist at Simbryo Technologies. Her research background is in cell biology, genetics, microbiology, mitochondrial stress/surveillance, and cellular response pathways. More recently, she has worked on Simbryo’s functional endometrial/embryo-transfer assays and reproductive-medicine applications.

scientific publications ->

Assem G. Ziady, PhD

PhD: Cell Physiology, Physiology and Biophysics, Case Western Reserve University

Professor in the UC Department of Pediatrics and researcher at Cincinnati Children’s. His work focuses on cystic fibrosis, inflammatory/redox signaling, nonviral gene delivery, DNA nanoparticles, proteomics, and biomarker discovery. He is also an inventor on multiple patents related to DNA nanoparticle technologies.

scientific publications ->

Alexey Revtovich, MS

MS in Engineering Physics / Applied Physics

Alexey V. Revtovich, MS — Microbiology and biomedical researcher specializing in host–pathogen interactions, antimicrobial resistance, pathogen virulence, innate immunity, mitochondrial stress biology, and high-throughput therapeutic discovery. His research includes phenotypic drug screening, antimicrobial peptides, immune modulators, anti-virulence strategies, and mitochondrial surveillance, with applications across infectious disease, host defense, and therapeutic development.

scientific publications ->

Dr. Khaled Diab

MD | Founder & Chief Medical Officer, Diab Longevity | Physician | Longevity, Regenerative Medicine & Human Performance Strategist

Dr. Khaled Diab is a physician, longevity medicine specialist, regenerative medicine practitioner, and human performance strategist dedicated to redefining the future of healthcare through precision medicine, advanced diagnostics, and biological optimization.

Dr. Annabelle Manalo Morgan

PhD | Global Scientific Advisor in Regenerative Medicine, Cellular Therapeutics, and Longevity Innovation

Dr. Annabelle Manalo Morgan is a neuroscientist and cellular biologist with experience across regenerative medicine, stem-cell technologies, exosome platforms, peptide systems, biotechnology development, and longevity-focused therapeutics. Her work bridges scientific research with product development, manufacturing strategy, regulatory considerations, and commercialization.

Justin Rundle, Esq

Chief Legal & Strategic Affairs Officer | Corporate Counsel | Transaction Architect | Strategic Growth Advisor

Justin Rundle is a distinguished business attorney, trusted strategic advisor, and accomplished transaction architect whose career has been dedicated to helping visionary entrepreneurs, investors, developers, healthcare organizations, and emerging growth companies transform ambitious ideas into scalable, investment-grade enterprises.